Emalex Biosciences

Emalex

This biopharmaceutical company develops ecopipam to treat Tourette syndrome and other neurological conditions for paediatric and adult patients.

IAMA Therapeutics

This company develops small molecule drugs to treat neurodevelopmental and central nervous system disorders for patients with autism and epilepsy.

Engrail

This clinical-stage pharmaceutical company develops targeted small-molecule medicines for patients with neuropsychiatric and neurodevelopmental disorders.

Noema Pharma

This company develops clinical-stage therapeutic products for patients with central nervous system disorders and orphan neurological conditions.

Addex Therapeutics

This biopharmaceutical company develops oral small molecule allosteric modulators for patients with neurological disorders, including addiction, Parkinson's disease, and chronic cough.

Confluence Pharmaceuticals

This company develops therapeutic treatments for social and communication impairments in patients with Fragile X Syndrome and autism spectrum disorders.

iQure Pharma

This clinical-stage biotech company develops astrocyte-targeted therapeutics to restore glutamate balance for patients with central nervous system disorders such as epilepsy and Parkinson's disease.

Engrail Therapeutics

This company develops small-molecule therapies for patients with neurologic, neuropsychiatric and neurodevelopmental disorders such as anxiety, depression and rare diseases.